The researchers also tried to reduce bias by adjusting for many differences between patients, such as health background and other factors that could affect who gets which drug
If you are considering GLP-1 agonist therapy or are uncertain whether metformin alone is sufficient, genetic context combined with baseline HbA1c, fasting glucose, and BMI can help guide a more personalized treatment plan
Tirzepatide (TZP
The time to plan is now As new uses for GLP-1 medications arise, we believe plan sponsors should start preparing now for increased demand and develop a program approach that balances appropriate access with maintaining benefit affordability
One box of Wegovy contains four single-dose pens, which provides four weekly injections (one month of treatment)
However, if you are finding that you cannot concentrate no matter what, a break might be exactly what you need